Nano-sulforaphane attenuates PhIP-induced early abnormal embryonic neuro-development

Ping Zhang, Tingting Li, Chang Liu, Mustafa Sindi, Xin Cheng, Shuangyu Qi, Xinyue Liu, Yu Yan, Beate Brand-Saberi, Yongping Bao, Wendong Yang, Guang Wang, Xuesong Yang

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
18 Downloads (Pure)


2-amino-1-methyl-6-phenylimidazo[4,5-b]pyrimidine (PhIP), one of the most abundant heterocyclic aromatic amines (HAA) formed by cooking meat at high temperatures, may modify humans and rodents through the metabolic process prior to affecting nervous system development. in humans and rodents may be modified by metabolic processes and then affecting nervous system development.
In this paper, PhIP was used to prepare a chicken embryo model with abnormal embryonic nervous system defects. Sulforaphane (SFN) is a derivative of a glucosinolate, which is abundant in cruciferous vegetables, and can pass through the placental barrier. Moreover, SFN has antioxidant and anti-apoptotic functions and is considered as a bioactive antioxidant with significant neuroprotective effects. Nano-sulforaphane (Nano-SFN, Sulforaphane nanoparticles) was prepared by self-assembly using biocompatible, biodegradable methoxy polyethylene glycol 5000-b-polyglutamic acid 10000 (mPEG5K-PGA10K) as the substrate, to explore the new application of Nano-SFN and its modified compounds as leading compounds in protecting against the abnormal development of the embryonic nervous system.
The results show that Nano-SFN could protect against PhIP-induced central nervous system (CNS, derived from neural tube) and peripheral nervous system (PNS, derived from neural crest cells, NCCs) defects and neural tube defects (NTDs), and increase the embryo survival rate.
This study indicates that Nano-SFN can effectively alleviate the developmental defects of embryonic nervous system induced by PhIP in the microenvironment and has a protective effect on embryonic development. It not only helps with expanding the application of SFN and improving its medicinal value, but also provides a possibility of SFN being developed as a novel drug for neuroprotection.
Original languageEnglish
Article number151617
JournalAnnals of Anatomy
Early online date21 Oct 2020
Publication statusPublished - Jan 2021


  • 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
  • Sulforaphane nanoparticles
  • Embryonic development
  • Neural tube
  • Neural crest cells

Cite this